Cardiovascular Systems, Inc. (NASDAQ:CSII) Director Edward M. Brown sold 20,000 shares of Cardiovascular Systems stock in a transaction dated Thursday, August 31st. The shares were sold at an average price of $29.16, for a total transaction of $583,200.00. The sale was disclosed in a filing with the SEC, which is accessible through this link.
Shares of Cardiovascular Systems, Inc. (NASDAQ CSII) traded down 1.10% during midday trading on Friday, reaching $30.45. 307,141 shares of the company’s stock traded hands. The stock’s 50 day moving average price is $30.19 and its 200 day moving average price is $30.13. The firm’s market capitalization is $1.00 billion. Cardiovascular Systems, Inc. has a 52-week low of $21.29 and a 52-week high of $33.11.
Cardiovascular Systems (NASDAQ:CSII) last issued its earnings results on Wednesday, August 2nd. The medical device company reported $0.02 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of ($0.05) by $0.07. Cardiovascular Systems had a positive return on equity of 0.88% and a negative net margin of 0.87%. The company had revenue of $52.90 million during the quarter, compared to the consensus estimate of $51.98 million. During the same period in the previous year, the company posted ($0.15) EPS. The firm’s revenue for the quarter was up 9.1% compared to the same quarter last year. On average, equities research analysts anticipate that Cardiovascular Systems, Inc. will post $0.01 EPS for the current fiscal year.
WARNING: “Insider Selling: Cardiovascular Systems, Inc. (CSII) Director Sells 20,000 Shares of Stock” was originally reported by The Ledger Gazette and is the sole property of of The Ledger Gazette. If you are reading this article on another website, it was illegally stolen and reposted in violation of United States & international copyright & trademark law. The correct version of this article can be read at https://ledgergazette.com/2017/09/16/edward-m-brown-sells-20000-shares-of-cardiovascular-systems-inc-csii-stock.html.
Several hedge funds and other institutional investors have recently modified their holdings of CSII. Teachers Advisors LLC boosted its stake in shares of Cardiovascular Systems by 62.1% during the 4th quarter. Teachers Advisors LLC now owns 95,895 shares of the medical device company’s stock worth $2,322,000 after acquiring an additional 36,735 shares during the period. Nationwide Fund Advisors boosted its stake in shares of Cardiovascular Systems by 26.1% during the 1st quarter. Nationwide Fund Advisors now owns 42,815 shares of the medical device company’s stock worth $1,211,000 after acquiring an additional 8,854 shares during the period. Acadian Asset Management LLC bought a new position in shares of Cardiovascular Systems during the 1st quarter worth approximately $1,657,000. First Quadrant L P CA bought a new position in shares of Cardiovascular Systems during the 1st quarter worth approximately $1,730,000. Finally, State of New Jersey Common Pension Fund D bought a new position in shares of Cardiovascular Systems during the 1st quarter worth approximately $424,000. Institutional investors own 74.70% of the company’s stock.
A number of equities research analysts recently weighed in on the stock. BidaskClub cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research note on Tuesday, August 1st. Zacks Investment Research cut shares of Cardiovascular Systems from a “hold” rating to a “sell” rating in a research report on Friday, August 4th. Bank of America Corporation cut shares of Cardiovascular Systems from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 21st. Finally, Needham & Company LLC reiterated a “buy” rating and issued a $37.00 price target (up from $32.00) on shares of Cardiovascular Systems in a research report on Friday, July 14th. Three investment analysts have rated the stock with a sell rating, four have given a buy rating and one has given a strong buy rating to the company’s stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $33.83.
Cardiovascular Systems Company Profile
Cardiovascular Systems, Inc is a medical technology company. The Company is engaged in treating patients suffering from peripheral and coronary artery diseases, including those with arterial calcium. The Company develops an orbital atherectomy technology for both peripheral and coronary commercial applications.
Receive News & Ratings for Cardiovascular Systems Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cardiovascular Systems Inc. and related companies with MarketBeat.com's FREE daily email newsletter.